Empyema(농흉) case study

본 내용은 " [A+] Empyema(농흉) case study " 의 원문 자료에서 일부 인용된 것입니다. 2023.09.20

문서 내 토픽

• 1. Empyema(농흉)

  농흉의 약 50%는 폐의 일차적인 병변으로 인해 흉막강이 오염되면서 발생한다. 그 원인으로는 폐결핵, 폐렴, 폐농양, 늑막염, 흉부 외상, 흉부 수술 후 이차 감염, 횡격막하 농양, 자발성 기흉의 합병증 및 전신 패혈증 등이 있다. 농흉은 흉막이 두꺼워지고 섬유성 조직이 폐와 흉벽을 유착시키기 때문에 치료하기가 매우 어렵다. 농흉 치료에는 초기 배농이 중요하며, 급성기인 경우 흉막액의 점도가 낮아 항생제 등으로 적절히 치료하면 폐가 팽창하여 원래의 형태로 돌아올 수 있다. 하지만 초기 치료에도 불구하고 충분한 배액이 어려운 경우가 있으며, 만성기로 넘어가서 기질화되기도 한다. 이런 경우에는 흉막 박피술을 시행해야 한다.

Easy AI와 토픽 톺아보기

• 1. Empyema(농흉)

  Empyema, also known as pleural empyema, is a serious medical condition characterized by the accumulation of pus in the pleural space, the area between the lungs and the chest wall. This condition can be a complication of pneumonia, lung abscess, or other respiratory infections, and if left untreated, it can lead to significant respiratory distress and even life-threatening complications. The primary symptoms of empyema include chest pain, fever, shortness of breath, and a persistent cough. In some cases, the patient may also experience weight loss, fatigue, and a general feeling of malaise. Diagnosis typically involves imaging tests, such as chest X-rays or CT scans, as well as the analysis of fluid samples obtained through thoracentesis, a procedure in which a needle is inserted into the pleural space to extract fluid for examination. Treatment for empyema typically involves a combination of antibiotics and drainage of the accumulated pus. In some cases, more invasive procedures, such as video-assisted thoracoscopic surgery (VATS) or open thoracotomy, may be necessary to remove the infected pleural tissue and promote healing. Early recognition and prompt treatment are crucial, as untreated empyema can lead to serious complications, including respiratory failure, sepsis, and even death. Overall, empyema is a serious medical condition that requires prompt and appropriate treatment to prevent potentially life-threatening complications. Increased awareness and early intervention are essential for improving patient outcomes and reducing the burden of this disease.